Medical and Healthcare

摘要

Like most cliches, the one about necessity being the mother of invention is often overused. In the case of Tal Golesworthy, a process engineer who designed and developed his own life-saving implant and then commercialised the device through his own start-up company it couldn't be more apt. Golesworthy suffers from Marfan Syndrome, an inherited disorder that can cause the aorta, the main arterial conduit from the heart, to dilate and ultimately rupture. The traditional treatment involves removing the damaged section of the valve and replacing it with a graft and a mechanical valve. This takes around five hours, involves a heart-lung bypass, and requires the patient to be placed on a life-long course of the blood-thinning drug Warfarin.